U.S. Markets open in 16 mins

A Look at Teva Pharmaceutical’s Third-Quarter Earnings

Daniel Collins
A Look at Teva Pharmaceutical’s Third-Quarter Earnings

Teva Pharmaceutical’s (TEVA) GAAP net income fell YoY (year-over-year) to -$273 million from $530.0 million in the third quarter, but rose YoY to $541.0 million from -$4.9 billion in the first nine months of this year. Teva’s GAAP diluted EPS fell YoY to -$0.27 from $0.52 in the third quarter, and to $0.53 from $4.85 in the first nine months of this year. The company’s non-GAAP net income and non-GAAP diluted EPS fell YoY to $694.0 million and $0.68, respectively, from $1.0 billion and $1 in the third quarter.